News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Glenning Robert
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/09/2023 |
4
| Glenning Robert (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns:
| Granted 16,253 options to buy
@ $26, valued at
$422.6k
|
|
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/07/2020 |
4
| Glenning Robert (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $59.795, valued at
$598k
|
|
01/25/2019 |
4
| Glenning Robert (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $42.4, valued at
$424k
|
|
01/09/2018 |
4
| Glenning Robert (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $59.14, valued at
$591.4k
|
|
01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/06/2016 |
4
| Glenning Robert (Director) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.
Txns:
| Granted 10,000 options to buy
@ $41.01, valued at
$410.1k
|
|
|
|